Barclays Issues Positive Forecast for Bath & Body Works (NYSE:BBWI) Stock Price

Bath & Body Works (NYSE:BBWI) had its price target upped by research analysts at Barclays from $28.00 to $34.00 in a report released on Tuesday,Benzinga reports. The firm currently has an “underweight” rating on the stock. Barclays‘s price objective indicates a potential downside of 4.97% from the stock’s previous close.

Several other research analysts have also commented on BBWI. Bank of America cut their price target on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft lowered their price target on Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a report on Monday, August 26th. Piper Sandler upped their price objective on Bath & Body Works from $35.00 to $36.00 and gave the company a “neutral” rating in a research note on Tuesday. JPMorgan Chase & Co. dropped their price objective on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Finally, Raymond James reduced their target price on shares of Bath & Body Works from $51.00 to $42.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and nine have given a buy rating to the company’s stock. According to data from MarketBeat, Bath & Body Works has a consensus rating of “Moderate Buy” and an average target price of $42.44.

Bath & Body Works Price Performance

Bath & Body Works stock opened at $35.78 on Tuesday. The stock’s fifty day moving average is $30.69 and its two-hundred day moving average is $35.74. The stock has a market cap of $7.84 billion, a PE ratio of 8.66, a P/E/G ratio of 0.98 and a beta of 1.79. Bath & Body Works has a 1-year low of $26.20 and a 1-year high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. On average, research analysts expect that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Insider Transactions at Bath & Body Works

In related news, CEO Gina Boswell acquired 6,000 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were acquired at an average price of $29.64 per share, with a total value of $177,840.00. Following the completion of the purchase, the chief executive officer now directly owns 242,987 shares in the company, valued at approximately $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. First Community Trust NA purchased a new position in shares of Bath & Body Works during the second quarter valued at approximately $30,000. True Wealth Design LLC lifted its stake in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after purchasing an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its holdings in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in shares of Bath & Body Works in the third quarter valued at $39,000. Finally, TD Private Client Wealth LLC increased its stake in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after purchasing an additional 331 shares during the last quarter. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.